The biosimilar was also approved to treat moderately to severely active Crohn’s disease and ulcerative colitis, and moderate to severe plaque psoriasis.
The biosimilar was also approved to treat moderately to severely active Crohn’s disease and ulcerative colitis, and moderate to severe plaque psoriasis.
While already common practice in Europe, the use of vascular ultrasound to diagnose giant cell arteritis has been limited in the United States. New research aims to change that.
While already common practice in Europe, the use of vascular ultrasound to diagnose giant cell arteritis has been limited in the United States. New research aims to change that.
A 26-year-old female comes to your office complaining of chronic left knee pain that has worsened over the last one to two weeks. She describes the pain as, “throbbing and aching.”
A 26-year-old female comes to your office complaining of chronic left knee pain that has worsened over the last one to two weeks. She describes the pain as, “throbbing and aching.”
Which item in this patient’s clinical profile is not associated with a significantly increased risk for perioperative cardiovascular complications and/or death?
Which item in this patient’s clinical profile is not associated with a significantly increased risk for perioperative cardiovascular complications and/or death?
A study of the COVID-19 Global Rheumatology Alliance—a registry of adults with rheumatic and musculoskeletal diseases (RMD) and presumed or confirmed cases of COVID-19 as reported by physicians—revealed that higher rates of death from the...
A study of the COVID-19 Global Rheumatology Alliance—a registry of adults with rheumatic and musculoskeletal diseases (RMD) and presumed or confirmed cases of COVID-19 as reported by physicians—revealed that higher rates of death from the...
Dr Mandal, from the University of California, presented research she conducted with colleagues on ways to alleviate the disproportionate levels of rheumatology care among communities of color and rural populations.
Dr Mandal, from the University of California, presented research she conducted with colleagues on ways to alleviate the disproportionate levels of rheumatology care among communities of color and rural populations.